APA (7th ed.) Citation

Berry, C., du Cros, P., Fielding, K., Gajewski, S., Kazounis, E., McHugh, T. D., . . . Nyang'wa, B. (2022). TB-PRACTECAL: Study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis. Trials, 23(1), 1. https://doi.org/10.1186/s13063-022-06331-8

Chicago Style (17th ed.) Citation

Berry, Catherine, et al. "TB-PRACTECAL: Study Protocol for a Randomised, Controlled, Open-label, Phase II-III Trial to Evaluate the Safety and Efficacy of Regimens Containing Bedaquiline and Pretomanid for the Treatment of Adult Patients with Pulmonary Multidrug-resistant Tuberculosis." Trials 23, no. 1 (2022): 1. https://doi.org/10.1186/s13063-022-06331-8.

MLA (9th ed.) Citation

Berry, Catherine, et al. "TB-PRACTECAL: Study Protocol for a Randomised, Controlled, Open-label, Phase II-III Trial to Evaluate the Safety and Efficacy of Regimens Containing Bedaquiline and Pretomanid for the Treatment of Adult Patients with Pulmonary Multidrug-resistant Tuberculosis." Trials, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1186/s13063-022-06331-8.